PURPOSE: To perform an update on the initial evaluation and follow-up of benign prostatic hyperplasia (BPH).
METHOD: A systematic review of recent literature was performed. Level of evidence of publications was evaluated.
RESULTS AND CONCLUSIONS: Objectives of the initial evaluation are to assess the link between low urinary tract symptoms (LUTS) and BPH, to evaluate the bother associated to LUTS, assess a complicated bladder outlet obstruction (BOO), diagnose an adenocarcinoma of the prostate if it modifies the therapeutic strategy, and establish an evolutive profile of the disease. Clinical assessment with digital rectal examination, evaluation of symptoms by a dedicated questionnaire and urine analysis are the first steps of BPH evaluation. Bladder diary is useful to objective storage symptoms. Uroflowmetry and post-void residual volume assessment are useful if BOO is suspected. Measure of serum creatinine and ultrasound exam of the urinary tract are second line explorations. Urine cytology, neurological evaluation, urethrocystoscopy, urodynamics with pressure-flow studies are useful if the link between LUTS and BPH is unclear. PSA dosage is used for prostate cancer screening or as a prognostic marker of BPH evolution.
Written by:
Descazeaud A, Robert G, Delongchamps NB, Cornu JN, Saussine C, Haillot O, Devonec M, Fourmarier M, Ballereau C, Lukacs B, Dumonceau O, Azzouzi AR Are you the author?
Service de chirurgie urologique, hôpital Dupuytren, CHU de Limoges, 2, avenue Martin-Luther-King, Limoges 87042, France.
Reference: Prog Urol. 2012 Jan;22(1):1-6
doi: 10.1016/j.purol.2011.09.011
PubMed Abstract
PMID: 22195998
[Article in French]